Evidence map›Paper›PMID 40788291›Full record

ArticleClinical and experimental dental research2025

Motivation for Smoking Cessation in Patients With Oral Squamous Cell Carcinoma-A One-Time Survey.

Lennart Johannes Gruber, Matthias Maximilian Bühler, Antonie Spillner, Stefan Andreas, Philipp Kauffmann, Henning Schliephake, Susanne Wolfer

Abstract read
In one paragraph

Article in Clinical and experimental dental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lennart Johannes GruberDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.ORCID 0000-0002-3379-4455
Matthias Maximilian BühlerDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.
Antonie SpillnerDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.
Stefan AndreasDepartment of Cardiology and Pneumology, University Medical Center Goettingen, Goettingen, Germany.
Philipp KauffmannDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.
Henning SchliephakeDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.
Susanne WolferDepartment of Oral and Maxillofacial Surgery, University Medical Center Goettingen, Goettingen, Germany.

Funding

The authors received no specific funding for this study.
6 · The paper itself

Abstract

objectivesTobacco smoking is one major risk factor in the development of oral squamous cell carcinoma (OSCC). Continuation of smoking after diagnosis and treatment is associated with an increase in recurrence rate and incidence of second tumors, with a shorter lon g-term survival and poorer response to therapy. In the current German guideline for the treatment of OSCC, there is no clear recommendation to participate in structured smoking cessation programs. MATERIALS AND

methodsA total of 202 patients with histologically confirmed OSCC completed a one-time assessment of their smoking behavior using three standardized questionnaires during regular tumor follow-up. In addition to sociodemographic data, patients were asked retrospectively about their smoking habits and motivation to quit smoking before and after diagnosis and treatment.

resultsA serious smoking cessation attempt before diagnosis of OSCC were stated in 54.8% of the participants. This number increased up to 82.2% after OSCC diagnosis. However, only 48.5% managed to quit smoking after diagnosis. Professional support was with only 21.92% (n = 16) rarely used. Motivation to quit was significantly lower before (2.75 ± 2.41) than after OSCC diagnosis (7.27 ± 2.41) (p = 0.001) and significantly higher among the participants who finally managed to quit (9.38 ± 1.68) than among those who continued smoking (4.79 ± 3.43) (p = 0.001).

conclusionsThe diagnosis of OSCC appears to be an important teachable moment for smoking cessation. To maximize this effect, an early and standardized implementation of systematic smoking cessation programs into the therapeutic concept of patients with OSCC is strongly recommended.

Indexed as

Carcinoma, Squamous CellMotivationMouth NeoplasmsSmoking CessationAdultAgedFemaleGermanyHumansMaleMiddle AgedRetrospective StudiesSmokingSurveys and Questionnairesmotivationoral squamous cell carcinomasmoking cessationtobacco smoking

Identifiers

PMID40788291
PMCPMC12337751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.